pd 142893 has been researched along with desoxycorticosterone in 1 studies
Studies (pd 142893) | Trials (pd 142893) | Recent Studies (post-2010) (pd 142893) | Studies (desoxycorticosterone) | Trials (desoxycorticosterone) | Recent Studies (post-2010) (desoxycorticosterone) |
---|---|---|---|---|---|
64 | 0 | 3 | 7,588 | 52 | 284 |
Protein | Taxonomy | pd 142893 (IC50) | desoxycorticosterone (IC50) |
---|---|---|---|
Solute carrier family 22 member 3 | Rattus norvegicus (Norway rat) | 8.4 | |
Solute carrier family 22 member 2 | Rattus norvegicus (Norway rat) | 1.9 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Champlain, J; Lamontagne, D; Millette, E | 1 |
1 other study(ies) available for pd 142893 and desoxycorticosterone
Article | Year |
---|---|
Contribution of endogenous endothelin in the enhanced coronary constriction in DOCA-salt hypertensive rats.
Topics: Angiotensin II; Animals; Coronary Circulation; Desoxycorticosterone; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Heart; Hypertension; In Vitro Techniques; Male; Nephrectomy; Oligopeptides; Propionates; Pyrimidines; Rats; Rats, Sprague-Dawley; Signal Transduction; Sodium Chloride; Vasoconstriction; Vasoconstrictor Agents; Vasopressins | 2003 |